137 related articles for article (PubMed ID: 9613146)
1. [Telomere, telomerase and cytogenetic changes in myelodysplastic syndromes].
Ohyashiki K; Ohyashiki JH
Nihon Rinsho; 1998 May; 56(5):1328-32. PubMed ID: 9613146
[TBL] [Abstract][Full Text] [Related]
2. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
Ohyashiki JH; Iwama H; Yahata N; Ando K; Hayashi S; Shay JW; Ohyashiki K
Clin Cancer Res; 1999 May; 5(5):1155-60. PubMed ID: 10353751
[TBL] [Abstract][Full Text] [Related]
3. Telomere shortening and chromosomal instability in myelodysplastic syndromes.
Lange K; Holm L; Vang Nielsen K; Hahn A; Hofmann W; Kreipe H; Schlegelberger B; Göhring G
Genes Chromosomes Cancer; 2010 Mar; 49(3):260-9. PubMed ID: 19998444
[TBL] [Abstract][Full Text] [Related]
4. Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.
Sashida G; Ohyashiki JH; Nakajima A; Sumi M; Kawakubo K; Tauchi T; Ohyashiki K
Clin Cancer Res; 2003 Apr; 9(4):1489-96. PubMed ID: 12684424
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?
Sieglová Z; Zilovcová S; Cermák J; Ríhová H; Brezinová D; Dvoráková R; Marková M; Maaloufová J; Sajdová J; Brezinová J; Zemanová Z; Michalová K
Leuk Res; 2004 Oct; 28(10):1013-21. PubMed ID: 15289012
[TBL] [Abstract][Full Text] [Related]
6. Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation.
Ohyashiki K; Iwama H; Yahata N; Tauchi T; Kawakubo K; Shimamoto T; Ohyashiki JH
Leuk Lymphoma; 2001 Jul; 42(3):291-9. PubMed ID: 11699393
[TBL] [Abstract][Full Text] [Related]
7. Telomeres and telomerase in normal and leukemic hematopoietic cells.
Engelhardt M; Wäsch R; Guo Y
Leuk Res; 2004 Oct; 28(10):1001-4. PubMed ID: 15289009
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in myelodysplastic syndromes.
Gürkan E; Tanriverdi K; Başlamişli F
Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
[TBL] [Abstract][Full Text] [Related]
9. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
[TBL] [Abstract][Full Text] [Related]
10. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes.
Ohyashiki JH; Ohyashiki K; Fujimura T; Kawakubo K; Shimamoto T; Iwabuchi A; Toyama K
Cancer Res; 1994 Jul; 54(13):3557-60. PubMed ID: 8012981
[TBL] [Abstract][Full Text] [Related]
11. Telomerase, hTERT and splice variants in patients with myelodysplastic syndromes.
Dong W; Qian Y; Yang L
Leuk Res; 2014 Jul; 38(7):830-5. PubMed ID: 24844605
[TBL] [Abstract][Full Text] [Related]
12. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
13. Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome.
Poloni A; Serrani F; Berardinelli E; Maurizi G; Mariani M; Costantini B; Trappolini S; Mancini S; Olivieri A; Leoni P
Leuk Res; 2013 Nov; 37(11):1538-44. PubMed ID: 24095110
[TBL] [Abstract][Full Text] [Related]
14. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
[TBL] [Abstract][Full Text] [Related]
15. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
[TBL] [Abstract][Full Text] [Related]
16. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines.
Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH
Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic alterations in myelodysplastic syndrome.
Mihara K; Takihara Y; Kimura A
Cytogenet Genome Res; 2007; 118(2-4):297-303. PubMed ID: 18000383
[TBL] [Abstract][Full Text] [Related]
18. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
[TBL] [Abstract][Full Text] [Related]
19. Telomeres and telomerase in hematologic neoplasia.
Ohyashiki JH; Sashida G; Tauchi T; Ohyashiki K
Oncogene; 2002 Jan; 21(4):680-7. PubMed ID: 11850796
[TBL] [Abstract][Full Text] [Related]
20. Lack of mutations of the human telomerase RNA gene (hTERC) in myelodysplastic syndrome.
Ohyashiki K; Shay JW; Ohyashiki JH
Haematologica; 2005 May; 90(5):691. PubMed ID: 15921388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
